Chiappetta, Marco
Lococo, Filippo
Sassorossi, Carolina
Aigner, Clemens
Ploenes, Till
Van Raemdonck, Dirk
Vanluyten, Cedric
Van Schil, Paul
Agrafiotis, Apostolos C.
Guerrera, Francesco
Lyberis, Paraskevas
Casiraghi, Monica
Spaggiari, Lorenzo
Zisis, Charalambos
Magou, Christina
Moser, Bernhard
Bauer, Jonas
Thomas, Pascal Alexandre
Brioude, Geoffrey
Passani, Stefano
Zsanto, Zalan
Sperduti, Isabella
Margaritora, Stefano
Article History
Received: 6 November 2023
Accepted: 5 March 2024
First Online: 26 March 2024
Change Date: 8 July 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1245/s10434-024-15808-6
Disclosure
: Dr. Paul VanSchil serves on advisory boards of AstraZeneca, BMS, MSD, Janssen, and Roche and received honoraria (personal and institutional) from them for lectures. Dr. Pascal A. Thomas is a consultant and serves as a scientific board member for Roche, AstraZeneca, BMS, and Amgen.